Ion Exchange (India) Ltd
Ion Exchange (India) Ltd
UtilitiesKey Fundamentals
MicrocapWater Supply & ManagementUtilitiesInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ion Exchange (India) Ltd insights
53 extracted metrics + investor summaries across FY13–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
3- Promoter holding is low: 25.4%
- Company might be capitalizing the interest cost
- Dividend payout has been low at 11.2% of profits over last 3 years
Growth Rate
AI Analysis — Bull vs Bear
Ion Exchange (India) Ltd trades at a market cap of ₹6,208 Cr with a PE of 42.7x despite a TTM profit decline of 26% and FY26 PAT margin compression to ~4.9%. The company has a strong long-term revenue CAGR of 13% over 10 years and operates in a structurally growing water treatment sector, but near-term profitability is under significant pressure from legacy project costs and margin erosion.
- 10-year compounded profit CAGR of 26% demonstrates long-term earnings power and scalability of the business model
- 10-year compounded sales CAGR of 13% and 5-year sales CAGR of 15% reflect consistent top-line growth in a secular demand environment
- Jal Jeevan Mission allocation of ₹67,670 Cr in FY27 budget — nearly 4x the FY26 revised estimate — provides a massive addressable opportunity for water treatment players
- Recent international order win of $52.83 million (~₹503 Cr) from Hyundai Engineering signals growing export competitiveness and order book diversification
- FY26 full-year revenue grew 7% YoY to ₹2,915 Cr, showing resilience in top-line despite margin headwinds
- 5-year ROE average of 20% and 10-year ROE average of 22% indicate historically efficient capital deployment
- Roha manufacturing plant commissioning expected to drive chemical segment growth and improve margins once fully ramped up
- 10-year stock CAGR of 29% reflects substantial long-term wealth creation track record
- TTM profit declined 26% with Q4 FY26 net profit crashing 62% YoY to ₹24.1 Cr, indicating severe near-term earnings deterioration
- PE ratio of 42.7x is elevated relative to the compressed TTM earnings, implying the stock prices in a recovery that is not yet visible in results
- FY26 PAT margin fell to ~4.9% for the full year, with Q4 FY26 PAT margin at just 2.8% and EBITDA margin at 2.3%, reflecting deep margin erosion
- Promoter holding is low at 25.4%, which limits promoter alignment and increases vulnerability to market volatility or hostile actions
- Last year ROE dropped to 12% from a 3-year average of 17%, signaling deteriorating return on equity
- Dividend payout has been low at 11.2% of profits over the last 3 years with a current yield of just 0.3%, offering minimal income support
- Company might be capitalizing interest costs, which could overstate reported asset values and understate true operating expenses
- 1-year stock return of -10% and 3-year CAGR of -7% show the market has de-rated the stock amid earnings disappointment
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- $52.83M Middle East order win Jul 10
Ion Exchange secured a USD 52.83 million contract from Hyundai Engineering for filtration units in the Middle East, with execution timeline of 18 months.
TL;DR: Ion Exchange has secured a significant international order worth $52.83M for filtration units in the Middle East, reinforcing its export capabilities and order book strength. No notable headwinds emerged in the period. The trend is positive with fresh order inflow providing revenue visibility over the next 18 months.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 479 | 533 | 554 | 782 | 568 | 644 | 691 | 835 | 583 | 734 | 734 | 863 | 700 |
| Expenses | 430 | 473 | 483 | 690 | 503 | 576 | 615 | 749 | 521 | 665 | 675 | 844 | 669 |
| Operating Profit | 48.78 | 60.39 | 70.58 | 91.99 | 64.21 | 68.3 | 75.47 | 85.74 | 62.54 | 68.49 | 59.25 | 19.74 | 31.74 |
| OPM % | 10.18% | 11.33% | 12.74% | 11.77% | 11.31% | 10.6% | 10.93% | 10.27% | 10.72% | 9.33% | 8.07% | 2.29% | 4.53% |
| Other Income | 8.69 | 10.65 | 9.44 | 16.85 | 11.43 | 14.53 | 8.91 | 14.84 | 18.2 | 14.62 | -4.43 | 43.13 | 6.36 |
| Interest | 2.05 | 3.56 | 3.22 | 3.23 | 2.93 | 3.62 | 3.3 | 3.61 | 2.56 | 3.08 | 7.57 | 10.79 | 8.95 |
| Depreciation | 7.87 | 8.5 | 9.62 | 10.42 | 10.44 | 10.89 | 11.33 | 11.83 | 12.26 | 12.17 | 18.57 | 19.6 | 21.75 |
| PBT | 47.55 | 58.98 | 67.18 | 95.19 | 62.27 | 68.32 | 69.75 | 85.14 | 65.92 | 67.86 | 28.68 | 32.48 | 7.4 |
| Tax % | 29.93% | 28.2% | 29.68% | 23.89% | 28.09% | 25.88% | 28.9% | 25.72% | 26.52% | 26.44% | 28.31% | 25.22% | 58.65% |
| Net Profit | 33.32 | 42.35 | 47.24 | 72.45 | 44.78 | 50.64 | 49.59 | 63.24 | 48.44 | 49.92 | 20.56 | 24.29 | 3.06 |
| EPS in Rs | 2.27 | 2.9 | 3.24 | 4.96 | 3.07 | 3.47 | 3.31 | 4.32 | 3.32 | 3.38 | 1.38 | 1.65 | 0.28 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 798 | 868 | 1,009 | 1,046 | 1,162 | 1,480 | 1,450 | 1,577 | 1,990 | 2,348 | 2,737 | 2,915 | 3,032 |
| Expenses | 750 | 810 | 935 | 966 | 1,053 | 1,342 | 1,243 | 1,361 | 1,731 | 2,072 | 2,440 | 2,705 | 2,853 |
| Operating Profit | 49 | 58 | 74 | 80 | 109 | 138 | 207 | 216 | 258 | 275 | 297 | 210 | 179 |
| OPM % | 6% | 7% | 7% | 8% | 9% | 9% | 14% | 14% | 13% | 12% | 11% | 7% | 6% |
| Other Income | 4 | 7 | 12 | 21 | 34 | 36 | 31 | 42 | 42 | 45 | 49 | 71 | 60 |
| Interest | 17 | 17 | 21 | 22 | 21 | 19 | 15 | 13 | 12 | 15 | 17 | 24 | 30 |
| Depreciation | 12 | 13 | 12 | 13 | 20 | 24 | 28 | 28 | 29 | 36 | 44 | 63 | 72 |
| PBT | 24 | 35 | 54 | 66 | 102 | 131 | 195 | 217 | 259 | 269 | 285 | 195 | 136 |
| Tax % | 52% | 51% | 46% | 40% | 35% | 28% | 27% | 26% | 25% | 27% | 27% | 27% | — |
| Net Profit | 11 | 17 | 29 | 40 | 66 | 94 | 143 | 162 | 195 | 195 | 208 | 143 | 98 |
| EPS in Rs | 0.67 | 1.05 | 2.07 | 2.74 | 4.45 | 6.38 | 9.81 | 11.1 | 13.41 | 13.37 | 14.17 | 9.73 | 6.69 |
| Div. Payout % | 43% | 28% | 16% | 12% | 10% | 9% | 10% | 9% | 9% | 11% | 10% | 12% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 142 | 156 | 153 | 186 | 246 | 349 | 492 | 641 | 819 | 1,004 | 1,194 | 1,325 |
| Borrowings | 86 | 90 | 111 | 165 | 110 | 122 | 62 | 55 | 59 | 152 | 323 | 482 |
| Other Liabilities | 437 | 456 | 689 | 699 | 795 | 896 | 875 | 914 | 1,047 | 1,271 | 1,449 | 1,559 |
| Total Liabilities | 679 | 715 | 967 | 1,064 | 1,164 | 1,382 | 1,443 | 1,625 | 1,939 | 2,441 | 2,979 | 3,380 |
| Fixed Assets | 85 | 103 | 99 | 145 | 161 | 194 | 190 | 192 | 215 | 367 | 392 | 754 |
| CWIP | 14 | 2 | 34 | 7 | 12 | 12 | 15 | 20 | 42 | 61 | 323 | 175 |
| Investments | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 9 | 10 | 12 | 13 | 16 |
| Other Assets | 578 | 608 | 831 | 909 | 987 | 1,172 | 1,234 | 1,404 | 1,672 | 2,001 | 2,250 | 2,435 |
| Total Assets | 679 | 715 | 967 | 1,064 | 1,164 | 1,382 | 1,443 | 1,625 | 1,939 | 2,441 | 2,979 | 3,380 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 45 | 50 | 176 | 86 | 127 | 102 | 197 | 91 | 63 | 130 | 32 | -28 |
| Investing | -17 | -25 | -75 | -167 | -70 | -17 | -27 | -93 | -41 | -160 | -165 | -44 |
| Financing | -29 | -17 | -3 | 31 | -79 | -28 | -75 | -27 | -15 | 8 | 128 | 100 |
| Net Cash Flow | -1 | 8 | 98 | -50 | -22 | 56 | 96 | -28 | 6 | -22 | -4 | 27 |
| Free Cash Flow | 29 | 21 | 132 | 57 | 96 | 70 | 167 | 42 | 3 | 10 | -287 | -280 |
| CFO/OP | 113 | 111 | 270 | 143 | 147 | 100 | 119 | 75 | 53 | 74 | 35 | 17 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 164 | 153 | 151 | 153 | 133 | 124 | 113 | 118 | 128 | 145 | 151 | 135 |
| Inventory Days | 55 | 53 | 68 | 55 | 65 | 51 | 52 | 70 | 65 | 59 | 63 | 87 |
| Days Payable | 221 | 215 | 206 | 197 | 207 | 188 | 219 | 202 | 162 | 174 | 165 | 177 |
| Cash Conversion Cycle | -2 | -9 | 12 | 11 | -9 | -13 | -54 | -14 | 31 | 31 | 50 | 44 |
| Working Capital Days | 5 | 3 | -48 | -72 | -64 | -51 | -53 | -27 | 5 | 16 | 33 | 53 |
| ROCE % | 16% | 20% | 27% | 27% | 33% | 35% | 40% | 36% | 34% | 27% | 22% | 14% |
Documents
Frequently Asked Questions about Ion Exchange (India) Ltd
What does Ion Exchange (India) Ltd do?
Where is Ion Exchange (India) Ltd (IONEXCHANG) listed?
Which sector does Ion Exchange (India) Ltd belong to?
What is the market capitalisation of Ion Exchange (India) Ltd?
What is the PE ratio of Ion Exchange (India) Ltd?
What is the 52-week high and low of Ion Exchange (India) Ltd?
Does Ion Exchange (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Ion Exchange (India) Ltd?
How can I research Ion Exchange (India) Ltd on Tapetide?
Company Information
Ion Exchange (India) is engaged in a wide range of solutions across the water cycle from pre-treatment to process water treatment, waste water treatment, recycle, zero liquid discharge, sewage treatment, packaged drinking water, sea water desalination etc.(Source : 201903 Annual Report Page No: 63)